Please join us at the annual MIT Research and Development Conference: Innovating at the Inflection Point: Creating a Better World on November 15-16, 2022 to hear from MIT researchers, MIT Startup Exchange entrepreneurs, and global business leaders dedicated to innovating to create a better world.
The webinar is taking place August 19. Register today!
Join MIT VMS for "AI-Enabled Startup Marketing" a revamped half-day boot camp designed to give founders and teams the edge as they go to market.
MIT Academic innovator: "AI killer apps for Energy," Kalyan Veeramachaneni, Principal Research Scientist, MIT Laboratory for Information and Decision Systems
P&G is looking to partner with companies and emerging disruptors to address key shopper and retailer pain points in urban to deliver a breakthrough experience which disproportionately drives P&G brands.
Panel discussion
What are the latest advances in energy innovation?
· The here and now: Where are we today? What new tech tools and approaches are available? What are the most successful energy startups from MIT doing at the moment and why?
· What’s on the near horizon? What new applications are opening up? What are the investment opportunities? What is the smart money focused on? What are corporate priorities in seeking novel energy tech? What does the new energy innovation ecosystem look like (infrastructure, interoperability, technology, use cases, stakeholders, success stories)?
· The future: What advances will we see over the next few years? What's in it for consumers? What are you personally the most excited about?
Panelists:
· Kalyan Veeramachaneni, Principal Research Scientist, MIT Laboratory for Information and Decision Systems
· Dave Truch, Technology Director, Digital Innovation Organization, BP
· Ben Sampson, Director, Energy, GE Ventures
· Tor Jakob Ramsoy, CEO & Founder, Arundo
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.